BioDrone Therapeutics Inc.
  • Home
  • About Us
  • More
    • Home
    • About Us
BioDrone Therapeutics Inc.
  • Home
  • About Us

Intellectual Properties

MDimune has developed a robust IP portfolio to provide freedom to operate. Additional composition of matter claims will be able to be generated to protect collaborative programs. 


  • Over 50 patents are filed from 10+ patent families
  • 18+ patents are registered globally, including  those with the  US, EU, China, Japan, and Korea
  • Patents in 4 main categories - extrusion technology, therapeutic use, targeted delivery, and drug loading

Copyright © 2022 BioDrone Therapeutics Inc. - All Rights Reserved.

  • Contact